Siga Technologies (SIGA) Net Cash Flow Growth (3y) (2013 - 2025)
Powered by 
Analysis
Siga Technologies (SIGA) Net Cash Flow Growth (3y) (2013 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 38.95% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | -49.89% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 33.59% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 38.53% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -51.84% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 1.06% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 18.67% |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 95.24% |
| 10 | Siga Technologies | 235.60 Mn | 80.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -30.01% |
| Jun 30, 2025 | 36.11% |
| Mar 31, 2025 | -48.44% |
| Dec 31, 2024 | 75.87% |
| Sep 30, 2024 | -10.67% |
| Jun 30, 2024 | -66.20% |
| Mar 31, 2024 | 17.95% |
| Dec 31, 2023 | 26.30% |
| Sep 30, 2023 | -30.04% |
| Jun 30, 2023 | -17.53% |
| Mar 31, 2023 | 30.10% |
| Dec 31, 2022 | 10.41% |
| Sep 30, 2022 | -181.64% |
| Jun 30, 2022 | -107.29% |
| Mar 31, 2022 | 863.50% |
| Dec 31, 2021 | -47.74% |
| Sep 30, 2021 | -27.38% |
| Jun 30, 2021 | -15.43% |
| Mar 31, 2021 | -9.89% |
| Dec 31, 2020 | 87.54% |